ClinicalTrials.gg
CompletedNCT05612503Updated Nov 10, 2022

Virtual Reality and Congenital Diaphragmatic Hernia

An interventional study of Traditional physical therapy program and Virtual reality-based exercises in Virtual Reality, Congenital Diaphragmatic Hernia and Children, sponsored by Qassim University. Completed at 1 site in Saudi Arabia. Open to participants aged 6 Years to 10 Years. Per ClinicalTrials.gov, last updated 2022-11-10.

Sponsored by Qassim University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Jan 2021, registered Oct 2022).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
6 Years to 10 Years
Sex
All
01

Study summary

The study has been designed to investigate the effect of 12 weeks of using virtual reality based exercises on pulmonary functions, exercise capacity, functional performance, and quality of life in children with surgically-repaired congenital diaphragmatic hernia.

Read the detailed description

Children with CDH have significant disruptions in their quality of life (QoL) due to their poor health, in this randomized controlled clinical trial, one important aspect of virtual reality is the interactivity of children and their interests in choosing the exercised game. Each child in two groups perform a specific virtual reality based respiratory exercises for 3 months.

02

Conditions studied

  • Virtual Reality
  • Congenital Diaphragmatic Hernia
  • Children
03

In context

Hernias, Diaphragmatic, Congenital

86 studies on the registry are indexed under Hernias, Diaphragmatic, Congenital; 39 are open to participants now.

This study's enrollment of 52 is above the median of 30 across 62 interventional studies indexed under Hernias, Diaphragmatic, Congenital.

Browse Hernias, Diaphragmatic, Congenital studies →

Lead sponsor

Qassim University is the lead sponsor of 50 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age between 6 and 10 years.
  • was between 20 and 24 kg/m2.
  • surgically-repaired congenital diaphragmatic hernia.
  • respiratory distress symptoms.
  • under follow-up care in pediatric and physical therapy clinic.

Exclusion criteria

Exclusion Criteria:

  • Children were excluded if they have growth abnormality.
  • neuromotor disorders.
  • children with cardiac problems.
  • unable to do understand all procedures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (actual)

Study arms

  • Sham comparator
    Traditional physical therapy program

    For 15 minutes, each child in both groups perform the following specific respiratory exercises: resistance-based diaphragm strengthening exercises, breathing exercises.

    Other: Traditional physical therapy program

  • Experimental
    Virtual reality-based exercises

    Following a session of traditional physical therapy, the children in study group toke 30 minutes rest then they joined in a 30-minute VR exercise session using Nintendo Wii systems.

    Other: Traditional physical therapy program · Other: Virtual reality-based exercises

Interventions

  • OtherTraditional physical therapy program

    resistance-based diaphragm strengthening exercises, breathing exercises to increase costal or chest breathing, and breathing exercises to relax the breathing muscles.

  • OtherVirtual reality-based exercises

    Virtual reality exercise using Nintendo Wii systems. As game interfaces, the Nintendo Wii systems employ haptic sensor-based controllers and a balance board.

06

What researchers measure

Primary outcomes

  1. Pulmonary function test, forced expiratory volume in the first second

    A pulmonary function test was conducted for all participants using a spirometry analyzer (Autospiro-507; Minato Medical Science; Osaka. Japan).

    Time frame: From date of randomization (first week of intervention)

  2. Pulmonary function test, forced expiratory volume in the first second

    A pulmonary function test was conducted for all participants using a spirometry analyzer (Autospiro-507; Minato Medical Science; Osaka. Japan).

    Time frame: after 12 weeks

  3. Pulmonary function test, forced vital capacity

    A pulmonary function test was conducted for all participants using a spirometry analyzer (Autospiro-507; Minato Medical Science; Osaka. Japan).

    Time frame: From date of randomization (first week of intervention)

  4. Pulmonary function test, forced vital capacity

    A pulmonary function test was conducted for all participants using a spirometry analyzer (Autospiro-507; Minato Medical Science; Osaka. Japan).

    Time frame: after 12 weeks

  5. Pulmonary function test, FEV1/FVC ratio

    performed using a spirometer (Autospiro-507; Minato Medical Science; Osaka. Japan)., (forced expiratory volume in the first second/ forced vital capacity) FEV1/FVC ratio was recorded.

    Time frame: From date of randomization (first week of intervention)

  6. Pulmonary function test, FEV1/FVC ratio

    performed using a spirometer (Autospiro-507; Minato Medical Science; Osaka. Japan)., (forced expiratory volume in the first second/ forced vital capacity) FEV1/FVC ratio was recorded.

    Time frame: after 12 weeks

  7. Exercise capacity assessment

    Cardiopulmonary pulmonary exercise test using the Bruce treadmill test was used to asess the exercise capacity.

    Time frame: From date of randomization (first week of intervention)

  8. Exercise capacity assessment

    Cardiopulmonary pulmonary exercise test using the Bruce treadmill test was used to asess the exercise capacity.

    Time frame: after 12 weeks

Secondary outcomes

  1. Functional performance assessment

    Functional performance was assessed through using the 6-min walk test.

    Time frame: From date of randomization (first week of intervention)

  2. Functional performance assessment

    Functional performance was assessed through using the 6-min walk test.

    Time frame: after 12 weeks

  3. Pediatric Quality of Life Inventory

    Quality of life was evaluated using self-report Pediatric Quality of Life Inventory (PedsQL), it is multidimensional measures of HRQL in children and adolescents, it includes 23 items distributed among 4 domains \[physical (8 items) , emotional( 5 items), social ( 5 items ), and school functions ( 3 items )\] including 23 items. It provides child self-report and parents report with 5- points scale ( 0 means never, and 4 means almost always).

    Time frame: From date of randomization (first week of intervention)

  4. Pediatric Quality of Life Inventory

    Quality of life was evaluated using self-report Pediatric Quality of Life Inventory (PedsQL), it is multidimensional measures of HRQL in children and adolescents, it includes 23 items distributed among 4 domains \[physical (8 items) , emotional( 5 items), social ( 5 items ), and school functions ( 3 items )\] including 23 items. It provides child self-report and parents report with 5- points scale ( 0 means never, and 4 means almost always).

    Time frame: after 12 weeks

07

Study locations

1 site
  • Outpatient Clinic of College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University
    Al Kharj, Riyadh Region 11432, Saudi Arabia
08

References and documents

Publications

  • van den Hout L, Schaible T, Cohen-Overbeek TE, Hop W, Siemer J, van de Ven K, Wessel L, Tibboel D, Reiss I. Actual outcome in infants with congenital diaphragmatic hernia: the role of a standardized postnatal treatment protocol. Fetal Diagn Ther. 2011;29(1):55-63. doi: 10.1159/000322694. Epub 2011 Feb 3. PubMed 21325859 ↗
  • Zaccara A, Turchetta A, Calzolari A, Iacobelli B, Nahom A, Lucchetti MC, Bagolan P, Rivosecchi M, Coran AG. Maximal oxygen consumption and stress performance in children operated on for congenital diaphragmatic hernia. J Pediatr Surg. 1996 Aug;31(8):1092-4; discussion 1095. doi: 10.1016/s0022-3468(96)90094-9. PubMed 8863241 ↗
  • Rutkowski S, Szczegielniak J, Szczepanska-Gieracha J. Evaluation of the Efficacy of Immersive Virtual Reality Therapy as a Method Supporting Pulmonary Rehabilitation: A Randomized Controlled Trial. J Clin Med. 2021 Jan 18;10(2):352. doi: 10.3390/jcm10020352. PubMed 33477733 ↗
  • Azab AR, Elnaggar RK, Abdelbasset WK, Alghadier M, Ahmed AS, Alsharidah AS, Morgan EN, Basha MA, Hassan MA, Kamel FH. Virtual reality-based exercises' effects on pulmonary functions, cardiopulmonary capacity, functional performance, and quality of life in children with repaired congenital diaphragmatic hernia. Eur Rev Med Pharmacol Sci. 2023 Jul;27(14):6480-6488. doi: 10.26355/eurrev_202307_33118. PubMed 37522659 ↗

Individual participant data

Plan to share: Yes — The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Supporting information: Study protocol, Informed consent form

Time frame: 6 months after publication

Access criteria: relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2021 to primary completion in Sep 2021, 7 months.

Of 40 interventional studies with no phase under Hernias, Diaphragmatic, Congenital, half reached primary completion within 108 months of starting (the median), counting those still running; a quarter within 33 and three quarters within 133. This study's 7 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 27, 2022
First posted
Nov 10, 2022
StartActual
Jan 10, 2021
Primary completionActual
Sep 9, 2021
CompletionActual
Apr 15, 2022
Last update
Nov 10, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05612503
Lead sponsor
Qassim University
Collaborators
Cairo University, Prince Sattam Bin Abdulaziz University
Responsible party
Maged Basha (Assistant Professor, College of Medical Rehabilitation, Qassim University, Qassim University) — Principal investigator
First posted
Nov 10, 2022
Start date
Jan 10, 2021
Primary completion
Sep 9, 2021
Completion
Apr 15, 2022
Last update
Nov 10, 2022

Study contacts

Alshimaa Azab, PhD
study director · Prince Sattam Bin Abdulaziz University
Ragab Elnaggar,, PhD
study chair · Prince Sattam Bin Abdulaziz University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion